Mba BEcon - Avicanna CEO CoFounder

AVCN Stock  CAD 0.26  0.01  3.70%   

Insider

Mba BEcon is CEO CoFounder of Avicanna
Phone647 243 5283
Webhttps://www.avicanna.com

Avicanna Management Efficiency

The company has return on total asset (ROA) of (0.2061) % which means that it has lost $0.2061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1231) %, meaning that it generated substantial loss on money invested by shareholders. Avicanna's management efficiency ratios could be used to measure how well Avicanna manages its routine affairs as well as how well it operates its assets and liabilities.
Avicanna has accumulated 1.8 M in total debt with debt to equity ratio (D/E) of 6.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avicanna has a current ratio of 4.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Avicanna until it has trouble settling it off, either with new capital or with free cash flow. So, Avicanna's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avicanna sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avicanna to invest in growth at high rates of return. When we think about Avicanna's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

INSIDER Age

MBA MBACardiol Therapeutics Class
N/A
Richard MohrCharlottes Web Holdings
64
Cory PalaCharlottes Web Holdings
N/A
Trevor BurnsCardiol Therapeutics Class
N/A
Perry AntelmanCharlottes Web Holdings
60
Andres GortariCharlottes Web Holdings
48
Bernard BScCardiol Therapeutics Class
N/A
Jacques TortoroliCharlottes Web Holdings
65
CA CMACardiol Therapeutics Class
N/A
Avicanna Inc. focuses on the research and development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts in North America, Latin America, Europe, and Asia. The company was founded in 2016 and is headquartered in Toronto, Canada. AVICANNA INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 77 people. Avicanna (AVCN) is traded on Toronto Exchange in Canada and employs 87 people. Avicanna is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Avicanna Leadership Team

Elected by the shareholders, the Avicanna's board of directors comprises two types of representatives: Avicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avicanna. The board's role is to monitor Avicanna's management team and ensure that shareholders' interests are well served. Avicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mba BEcon, CEO CoFounder
Arash MBA, Executive Technology
Karolina Urban, Executive Affairs
Roland Alvarez, SVP Operations
Ingrid Diaz, Assistant VP
Frantz Devedec, Executive Development
Caitlin Johnston, VP Access
Stephen Kim, Chief Inc
Enric Pujol, Vice People
Ivana Maric, Executive Marketing
Carlos Muete, SVP Development

Avicanna Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avicanna a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Other Information on Investing in Avicanna Stock

Avicanna financial ratios help investors to determine whether Avicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.